Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
08/10/2000 | CA2362126A1 B7rp-1 polypeptides |
08/10/2000 | CA2361816A1 Substituted pyrazole carboxylic acids used to combat anaemias |
08/10/2000 | CA2361805A1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same |
08/10/2000 | CA2361589A1 Calcilytic compounds |
08/10/2000 | CA2361551A1 Method for controlling liposome size |
08/10/2000 | CA2361539A1 Compressed lecithin preparations |
08/10/2000 | CA2361459A1 Use of cationic lipids to generate anti-tumor immunity |
08/10/2000 | CA2361191A1 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site |
08/10/2000 | CA2360942A1 Preparations for preventing and/or treating a tissue change of mesenchymal origin |
08/10/2000 | CA2360941A1 Liposome composition and method for administration of a radiosensitizer |
08/10/2000 | CA2360893A1 Tau-conotoxin peptides |
08/10/2000 | CA2360878A1 Gene repair involving excision of targeting dna |
08/10/2000 | CA2360865A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
08/10/2000 | CA2360796A1 Improved helper dependent vector system for gene therapy |
08/10/2000 | CA2360684A1 Method for inducing differentiation into adipocytes, compounds controlling such differentiation and method of screening for same |
08/10/2000 | CA2358895A1 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists |
08/10/2000 | CA2358894A1 Tricyclic pyridine n-oxides vasopressin agonists |
08/10/2000 | CA2358892A1 Pyrrolobenzodiazepine carboxyamide vasopressin agonists |
08/10/2000 | CA2358891A1 Thienylbenzoylbenzazepines as vasopressin agonists |
08/10/2000 | CA2358855A1 Benzazepine derivatives as alpha-v integrin receptor antagonists |
08/10/2000 | CA2357013A1 Anti-inflammatory indole derivatives |
08/10/2000 | CA2356898A1 Indole derivatives and their use as mcp-1 antagonists |
08/09/2000 | EP1026253A2 Expression of exogenous polynucleotide sequences in a vertebrate |
08/09/2000 | EP1026157A2 Method for the synthesis of huperzine A and analogs thereof and compounds useful therein |
08/09/2000 | EP1025871A1 Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair |
08/09/2000 | EP1025849A1 Methods for detection and treatment of individuals having abnormal cells expressing HLA-A2/tyrosinase peptide antigens |
08/09/2000 | EP1025834A1 Use for direct hair dye a combination of two cationic dyes |
08/09/2000 | EP1025238A2 Death associated kinase containing ankyrin repeats (dakar) |
08/09/2000 | EP1025231A1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance |
08/09/2000 | EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof |
08/09/2000 | EP1025211A2 Hyaluronan synthase gene and uses thereof |
08/09/2000 | EP1025122A1 Fibroblast growth factor with hepatocyte proliferation activity |
08/09/2000 | EP1025109A1 Benzoxazine derivatives, preparation and application in therapy |
08/09/2000 | EP1025105A1 Condensed benzothiopyranic compounds |
08/09/2000 | EP1025103A1 Novel polymorphic forms of cipamfylline |
08/09/2000 | EP1025102A1 Bicyclic kinase inhibitors |
08/09/2000 | EP1025100A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use |
08/09/2000 | EP1025098A1 Benzothiophenes |
08/09/2000 | EP1025090A1 Vitronectin receptor antagonists |
08/09/2000 | EP1025087A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
08/09/2000 | EP1025086A1 Benzamidine derivatives as factor xa inhibitors |
08/09/2000 | EP1025085A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof |
08/09/2000 | EP1024823A1 Prevention and treatment of adhesion formation |
08/09/2000 | EP1024822A1 Cd8 as an inhibitor of the cellular immune system |
08/09/2000 | EP1024819A1 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
08/09/2000 | EP1024815A1 Pharmaceutical compositions for oral administration of molecular iodine |
08/09/2000 | EP1024813A1 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease |
08/09/2000 | EP1024809A1 Use of immunomodulating agents |
08/09/2000 | EP1024806A1 Use of non-immunosuppressive compounds for promoting nerve regeneration |
08/09/2000 | EP1024804A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels |
08/09/2000 | EP1024802A1 (3$i(R),4$i(R))-$g(D)-TETRAHYDROCANNABINOL-11-OIC ACIDS USEFUL AS ANTIINFLAMMATORY AGENTS AND ANALGESICS |
08/09/2000 | EP1024801A2 Method for regulating size and growth of vascularized normal tissue |
08/09/2000 | EP1024799A1 Method for treating disease-related or drug-induced dyskinesias |
08/09/2000 | EP1024798A1 Neomycin/disaccharide water solution for enteroclysis in hepatic encephalopathy |
08/09/2000 | EP1024701A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
08/09/2000 | EP0820434B1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives |
08/09/2000 | EP0734384B1 3-substituted 1-arylindole compounds |
08/09/2000 | EP0732915B1 Local delivery of fibrinolysis enhancing agents |
08/09/2000 | EP0642519B1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism |
08/09/2000 | EP0642513B1 Indolocarbazole imides and their use |
08/09/2000 | EP0641201B1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids |
08/09/2000 | EP0533846B1 The ciliary neurotrophic factor receptor |
08/09/2000 | CN1262681A 4,5-dihydro-[1H]-benz [g] indazole-3-carboxylic acid derivatives |
08/09/2000 | CN1262680A 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy |
08/09/2000 | CN1262679A IL-5 inhibiting 6-azauracil derivatives |
08/09/2000 | CN1262678A Triazole compounds and use thereof as dopamine-D3-ligands |
08/09/2000 | CN1262677A Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, noval compounds thereof and their use as chemotherapeutic agents |
08/09/2000 | CN1262676A 吡啶衍生物 Pyridine derivatives |
08/09/2000 | CN1262675A (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers |
08/09/2000 | CN1262674A Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
08/09/2000 | CN1262627A Composition |
08/09/2000 | CN1262624A Use of colchinol derivatives as vascular damaging agents |
08/09/2000 | CN1262621A Gastrokinetic bicyclc benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
08/09/2000 | CN1262600A Compositions and method for reducing respiratory depression and attendant side effects of mu opioid compounds |
08/09/2000 | CN1262272A HIV proteinase inhibitor |
08/09/2000 | CN1262120A Medicinal ox horn |
08/09/2000 | CN1055213C Health-care medicinal liquor |
08/08/2000 | US6100387 Chimeric polypeptides containing chemokine domains |
08/08/2000 | US6100299 Tumor necrosis factor inhibitor; anticarcinogenic agents, antiinflammatory agents |
08/08/2000 | US6100297 Administering antioxidant cardioplegic solution during coronary bypass surgery |
08/08/2000 | US6100294 For treatment of metabolic, glandular, and bone disorders caused by vitamin deficiency |
08/08/2000 | US6100289 Indole derivatives |
08/08/2000 | US6100284 Antiallergens |
08/08/2000 | US6100283 Prodrug phosphate derivative for poly (adp-ribose) polymerase enzyme inhibitor for administering in conjunction with antitumor drug or radiotherapy |
08/08/2000 | US6100282 Thiazole derivatives |
08/08/2000 | US6100278 N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
08/08/2000 | US6100277 Retroviral protease inhibitor combinations |
08/08/2000 | US6100273 Water soluble camptothecin derivatives |
08/08/2000 | US6100272 Tetracyclic spiro compounds as 5HT1B receptor antagonists |
08/08/2000 | US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents |
08/08/2000 | US6100270 Bicyclic heterocyclic compounds for the treatment of impotence |
08/08/2000 | US6100267 Enzyme inhibitor for treatment of neurodegenerative disorders, strokes, traumatic brain injury, cataracts |
08/08/2000 | US6100264 5H, 10H-imidazo [1,2-A] indeno [1,2-E] pyrazin-4-one derivatives, their preparation, their intermediates and medicaments containing them |
08/08/2000 | US6100259 Cannabinoid receptor modulators |
08/08/2000 | US6100252 Specified compounds including methyl 2-butyl-1-((2'-(2-oxo-3h-1,2,3,5-oxathiadiazol-4-yl)biphenyl) methyl)-benzimidazole-7-carboxylate; use to treat circulatory diseases such as hypertensive diseases and heart diseases |
08/08/2000 | US6100249 Use of aspirin for the manufacture of a medicament for implanting an embryo into the uterine endometrium |
08/08/2000 | US6100246 Spiro-piperidine derivatives as inhibitors of nitric oxide synthase |
08/08/2000 | US6100237 Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis |
08/08/2000 | US6100059 Compounds |
08/08/2000 | US6100048 Using a panel of mammalian cells transformed with recombinant expression constructs encoding a variety of melanocortin receptors; contacting cells with compound, detecting binding, and determing if compound inhibits feeding behavior |